AstraZeneca Whittles Down Seroquel Case

Law360, New York (August 7, 2007, 12:00 AM EDT) -- In an increasingly bitter dispute in the multidistrict litigation over antipsychotic drug Seroquel, AstraZeneca LP asked a federal court on Tuesday to force the plaintiffs to substitute a case scheduled for discovery in September.

The drug company's request, filed in the U.S. District Court for the Middle District of Florida, came a day after it sought to have seven “improperly named defendants,” which include three units of AstraZeneca, dismissed from the case.

With more than 7,000 plaintiffs involved in the case over whether the drug causes...
To view the full article, register now.